Home > Insider Trading > Filing (0001209191-22-008983)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1595893	Turning Point Therapeutics Inc.	TPTX	Pharmaceutical Preparations (2834)	463826166

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1758838	John Andrew Partridge	10628 Science Center Drive San Diego CA 92121	Evp & Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2022-02-09	221	$36.30	22,078	No	4	S	Direct
Common Stock	Acquisiton	2022-02-09	16,283	$0.00	38,361	No	4	A	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	A	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Acquisiton	2022-02-09	58,600	$0.00	58,600	$37.68

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
58,600		2032-02-08	No	4	A	Direct

Footnotes

Sale of shares of common stock to cover tax withholding obligations associated with the vesting of a restricted stock unit award granted to Reporting Person on February 8, 2021.
The Reporting Person acquired 199 shares on June 10, 2021 pursuant to the Issuer's Employee Stock Purchase Plan (the "ESPP") and 333 shares on December 10, 2021 pursuant to the ESPP.
Represents restricted stock unit award granted under the Issuer's 2019 Equity Plan.
1/48th of the shares vest monthly following February 9, 2022.